Growth Metrics

Waystar Holding (WAY) Equity Ratio (2023 - 2026)

Waystar Holding's quarterly Equity Ratio came in at 0.67 in Q1 2026, little changed year-on-year from 0.68 in Q1 2025, and up 0.57% quarter-over-quarter from 0.67 in Q4 2025.

Waystar Holding has reported Equity Ratio for 4 years, with the latest figure at 0.67 in Q1 2026.

  • For the quarter ending Q1 2026, Equity Ratio changed 0.35% year-over-year to 0.67; the trailing twelve-month figure through Mar 2026 stood at 0.67 (changed 0.35% YoY), and the FY2025 full-year result was 0.67, changed 0.36% from the prior year.
  • Equity Ratio for Q1 2026 stood at 0.67, up from 0.67 in the prior quarter.
  • The five-year high for Equity Ratio was 0.68 in Q3 2025, with the low at 0.45 in Q4 2023.
  • Average Equity Ratio over 4 years is 0.65, with a median of 0.67 recorded in 2024.
  • Year-over-year, Equity Ratio surged 50.43% in 2024 and declined 0.36% in 2025.
  • Tracing WAY's Equity Ratio over 4 years: stood at 0.45 in 2023, then surged by 50.43% to 0.67 in 2024, then declined by 0.36% to 0.67 in 2025, then advanced by 0.57% to 0.67 in 2026.
  • The last three Equity Ratio figures came in at 0.67 (Q1 2026), 0.67 (Q4 2025), and 0.68 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Equity Ratio (Qtr)
1 Veeva Systems 30.85 Bn 24.28 Bn 622.47 Mn 0.80
2 BrightSpring Health Services 12.29 Bn 11.41 Bn 482.22 Mn 0.32
3 Healthequity 7.80 Bn 7.48 Bn 256.31 Mn 0.62
4 Hinge Health 4.82 Bn 4.51 Bn 154.23 Mn 0.15
5 Doximity 4.21 Bn 3.46 Bn 125.97 Mn 0.85
6 Waystar Holding 4.18 Bn 4.03 Bn 268.04 Mn 0.67
7 10x Genomics 3.78 Bn 3.24 Bn 106.18 Mn 0.80
8 Privia Health 2.65 Bn 2.28 Bn 595.71 Mn 0.53
9 Omnicell 1.95 Bn 1.78 Bn 140.36 Mn 0.63
10 Teladoc Health 1.42 Bn 672.39 Mn 562.57 Mn 0.48

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 0.67
Dec 31, 2025 0.67
Sep 30, 2025 0.68
Jun 30, 2025 0.68
Mar 31, 2025 0.68
Dec 31, 2024 0.67
Sep 30, 2024 0.67
Jun 30, 2024 0.65
Dec 31, 2023 0.45